Tag:
Fortesta
Latest Headlines
Latest Headlines
Endo gets green light for new testosterone gel
The FDA is giving a green light to a new testosterone gel developed by Endo Pharmaceuticals ( $ENDP ) and ProStrakan. Shares of Endo were buoyed by the news, Reuters notes. Fortesta was studied as a
Endo inks $210M deal for testosterone therapy
Endo Pharmaceuticals has handed out a $10 million upfront payment for the U.S. licensing rights to ProStrakan's testosterone replacement therapy Fortesta. The UK's ProStrakan also stands to gain $200
